Form 4 Filing for Camp4 Therapeutics Corp

Richard A. Young, a director at Camp4 Therapeutics Corp, acquired 16,378 shares of common stock on August 3, 2026, in the second closing of a private placement. The shares were purchased at a price of $1.65 per share, as detailed in a Securities Purchase Agreement dated September 9, 2025, and amended on August 3, 2026. This transaction, executed under a private placement with institutional investors, directors, employees, and consultants, brings Mr. Young's total post-transaction shares to 186,388. The filing also notes the purchase price was subject to a footnote (F1) referencing the private placement agreement.